Brain targeting PBCA nanoparticles and the blood––brain barrier

ISSN： 1743-5889

Source： Nanomedicine, Vol.4, Iss.5, 2009-07, pp. : 499-502

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood––brain barrier

By Tosi Giovanni Fano Rita Adriana Bondioli Lucia Badiali Luca Benassi Rois Rivasi Francesco Ruozi Barbara Forni Flavio Vandelli Maria Angela

Nanomedicine, Vol. 6, Iss. 3, 2011-04 ,pp. : 423-436

Future Medicine

Access to resources Recommend Favorite

Blood–brain barrier: An impediment to neuropharmaceuticals

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. : 308-313

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reading and Writing the Blood-Brain Barrier: Relevance to Therapeutics

Recent Patents on CNS Drug Discovery, Vol. 1, Iss. 2, 2006-01 ,pp. : 157-173

Bentham Science Publishers

Access to resources Recommend Favorite

Radiopharmaceuticals for assessing ABC transporters at the blood–brain barrier

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. : 362-371

John Wiley & Sons Inc

Access to resources Recommend Favorite

Regulation of ABC transporters at the blood–brain barrier

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. : 395-403

John Wiley & Sons Inc

Access to resources Recommend Favorite